The new images were captured at the European Synchrotron Radiation Facility using hierarchical phase-contrast tomography. One specialist called them "Google Earth for the human heart." 

Inspired by nature and funded by the European Research Council, a group of scientists and engineers thinks its new research could represent a significant breakthrough in TAVR care.

Leadless pacemakers may be an "attractive alternative" to transvenous devices when cardiologists treat older TAVR patients who experience conduction disorders.

U.S. News and World Report reviewed 660 hospitals, ranking them based on data related to treating diabetes and endocrinology. 

HeartFlow is using SCCT 2024 to introduce the world to its updated Plaque Analysis platform. “Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment," Chief Medical Officer Campbell Rogers, MD, explained.

The American Society of Nuclear Cardiology explored some key points included in the 2025 Medicare Physician Fee Schedule proposed rule.

The Society of Cardiovascular Computed Tomography has developed a new expert consensus document designed to get physicians on the same page when discussing this growing technology. 

Emily Lau, MD, a women's health expert with Massachusetts General Hospital, thinks major changes are needed in how we diagnose CVD in women. "Our guidelines need to be more precise and offer sex-specific recommendations," she says.

The 55-year-old cardiologist was allowed to continue practicing cardiology after his first conviction in 2016. Now, he is losing his license and faces up to eight years in prison. 

In rural Oklahoma, double amputees due to untreated peripheral artery disease face mortality rates around 35% after one year and 60% after two. Jim Melton, DO, hopes his mobile cardiology clinics can make a difference for these patients.

U.S. News & World Report is back with its latest rankings. Did your facility make the cut? 

Edwards, an early investor when the company first launched in 2017, said the acquisition will ensure its TMVR platform reaches as many patients as possible. 

Care teams are always looking for new ways to limit the use of permanent pacemakers after TAVR. Could starting patients off with temporary devices be an answer?